Skip to main navigation Skip to search Skip to main content

Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)

  • Musa Yilmaz
  • , Mansour Alfayez
  • , Courtney D. DiNardo
  • , Gautam Borthakur
  • , Tapan M. Kadia
  • , Marina Y. Konopleva
  • , Sanam Loghavi
  • , Rashmi Kanagal-Shamanna
  • , Keyur P. Patel
  • , Elias J. Jabbour
  • , Guillermo Garcia‑Manero
  • , Naveen Pemmaraju
  • , Sherry A. Pierce
  • , Issa Ghayas
  • , Nicholas J. Short
  • , Guillermo Montalban-Bravo
  • , Koichi Takahashi
  • , Rita Assi
  • , Ahmad S. Alotaibi
  • , Maro Ohanian
  • Michael Andreeff, Jorge E. Cortes, Hagop M. Kantarjian, Farhad Ravandi, Naval G. Daver

Research output: Contribution to journalComment/debatepeer-review

Abstract

The original article [18] mistakenly contains duplicate references. The correct reference list can be viewed in this Correction article.

Original languageEnglish (US)
Article number34
JournalJournal of Hematology and Oncology
Volume14
Issue number1
DOIs
StatePublished - Dec 2021
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Hematology
  • Molecular Biology
  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML (Journal of Hematology & Oncology, (2020), 13, 1, (132), 10.1186/s13045-020-00964-5)'. Together they form a unique fingerprint.

Cite this